CorMedix, Inc. (CRMD)
9.07
+0.30
(+3.42%)
USD |
NASDAQ |
Jun 11, 15:20
CorMedix Total Assets (Quarterly) : 815.64M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 815.64M |
| December 31, 2025 | 877.63M |
| September 30, 2025 | 750.86M |
| June 30, 2025 | 252.60M |
| March 31, 2025 | 149.58M |
| December 31, 2024 | 118.85M |
| September 30, 2024 | 77.59M |
| June 30, 2024 | 57.73M |
| March 31, 2024 | 68.02M |
| December 31, 2023 | 82.06M |
| September 30, 2023 | 91.43M |
| June 30, 2023 | 57.03M |
| March 31, 2023 | 59.23M |
| December 31, 2022 | 62.04M |
| September 30, 2022 | 62.08M |
| June 30, 2022 | 67.75M |
| March 31, 2022 | 64.93M |
| December 31, 2021 | 68.95M |
| September 30, 2021 | 75.39M |
| June 30, 2021 | 80.86M |
| March 31, 2021 | 84.26M |
| December 31, 2020 | 49.31M |
| September 30, 2020 | 40.02M |
| June 30, 2020 | 24.24M |
| March 31, 2020 | 27.40M |
| Date | Value |
|---|---|
| December 31, 2019 | 29.48M |
| September 30, 2019 | 33.72M |
| June 30, 2019 | 27.56M |
| March 31, 2019 | 27.31M |
| December 31, 2018 | 18.83M |
| September 30, 2018 | 8.049M |
| June 30, 2018 | 5.926M |
| March 31, 2018 | 9.609M |
| December 31, 2017 | 13.45M |
| September 30, 2017 | 13.93M |
| June 30, 2017 | 21.16M |
| March 31, 2017 | 14.93M |
| December 31, 2016 | 21.91M |
| September 30, 2016 | 28.84M |
| June 30, 2016 | 31.21M |
| March 31, 2016 | 33.61M |
| December 31, 2015 | 37.10M |
| September 30, 2015 | 39.31M |
| June 30, 2015 | 38.80M |
| March 31, 2015 | 9.752M |
| December 31, 2014 | 5.098M |
| September 30, 2014 | 6.845M |
| June 30, 2014 | 8.256M |
| March 31, 2014 | 9.761M |
| December 31, 2013 | 2.968M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Filana Therapeutics, Inc. | 108.37M |
| Eloxx Pharmaceuticals, Inc. | 8.503M |
| Cannabis Global, Inc. | 0.885M |
| BioStem Technologies, Inc. | 55.08M |
| Axsome Therapeutics, Inc. | 713.61M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 378.59M |
| Shareholders Equity (Quarterly) | 437.05M |
| Debt to Equity Ratio | 0.3315 |
| Current Ratio | 2.975 |
| Net Debt Paydown Yield | -5.42% |